galangin
SMILES | Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccccc1 |
InChIKey | VCCRNZQBSJXYJD-UHFFFAOYSA-N |
Chemical properties
Hydrogen bond acceptors | 5 |
Hydrogen bond donors | 3 |
Rotatable bonds | 1 |
Molecular weight (Da) | 270.1 |
Drug properties
Molecular type | Small molecule |
Physiological/Surrogate | Surrogate |
Approved drug | No |
Database connections
Ligand site mutations | A2A |
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
A1 | AA1R | Rat | Adenosine | A | pKi | 6.06 | 6.06 | 6.06 | ChEMBL |
A3 | AA3R | Human | Adenosine | A | pKi | 5.5 | 5.5 | 5.5 | ChEMBL |
A2A | AA2AR | Human | Adenosine | A | pKi | 4.48 | 4.67 | 4.78 | ChEMBL |
A2A | AA2AR | Human | Adenosine | A | pKi | 6.0 | 6.0 | 6.0 | Guide to Pharmacology |
A3 | AA3R | Human | Adenosine | A | pKi | 5.5 | 5.5 | 5.5 | Guide to Pharmacology |
A1 | AA1R | Rat | Adenosine | A | pKi | 6.1 | 6.1 | 6.1 | Guide to Pharmacology |
A2A | AA2AR | Rat | Adenosine | A | pKi | 6.01 | 6.01 | 6.01 | ChEMBL |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |